The global personal care stand-up pouches market size reached US$ 1.90 billion in 2023 and is projected to hit around US$ 4.93 billion by 2034, expanding at a CAGR of 9.05% during the forecast period from 2024 to 2034.
| Metric | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | TTM |
| Total revenue | 3.25 B | 3.41 B | 3.54 B | 3.35 B | 3.24 B | 3.33 B | 5.08 B | 5.75 B | 17.40 B |
| YoY growth | −10.73% | −7.03% | −3.76% | −2.61% | −0.34% | −2.26% | 43.73% | 71.34% | |
| Cost of goods sold | −2.63 B | −2.72 B | −2.78 B | −2.70 B | −2.61 B | −2.68 B | −4.31 B | −4.76 B | −14.36 B |
| Gross profit | 622.00 M | 692.00 M | 754.00 M | 658.00 M | 627.00 M | 654.00 M | 770.00 M | 988.00 M | 3.04 B |
| YoY growth | −6.75% | 3.28% | 4.43% | 1.86% | 0.80% | −5.49% | 2.12% | 50.15% | |
| Operating expenses (excl. COGS) | −327.00 M | −355.00 M | −355.00 M | −343.00 M | −322.00 M | −330.00 M | −446.00 M | −477.00 M | −1.58 B |
| Operating income | 295.00 M | 337.00 M | 399.00 M | 315.00 M | 305.00 M | 324.00 M | 324.00 M | 511.00 M | 1.46 B |
| YoY growth | −14.49% | 3.37% | 8.42% | −0.63% | 3.39% | −3.86% | −18.80% | 62.22% | |
| Non-operating income (total) | −130.00 M | −107.00 M | −80.00 M | −79.00 M | −81.00 M | −87.00 M | −371.00 M | −202.00 M | −741.00 M |
| Pretax income | 165.00 M | 230.00 M | 318.00 M | 236.00 M | 224.00 M | 237.00 M | −47.00 M | 309.00 M | 723.00 M |
| YoY growth | −66.60% | 7.98% | 26.19% | 21.65% | 35.76% | 3.04% | −114.78% | 30.93% | |
| Equity in earnings | −1.00 M | −1.00 M | −1.00 M | 0 | 1.00 M | 0 | 2.00 M | 2.00 M | 5.00 M |
| Taxes | −28.00 M | −40.00 M | −56.00 M | −43.00 M | −58.00 M | −40.00 M | 6.00 M | −49.00 M | −141.00 M |
| Non-controlling/minority interest | −2.00 M | −2.00 M | −4.00 M | −2.00 M | −4.00 M | −1.00 M | 0 | 0 | −5.00 M |
| After tax other income/expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |
| Net income before discontinued operations | 134.00 M | 187.00 M | 257.00 M | 191.00 M | 163.00 M | 196.00 M | −39.00 M | 262.00 M | 582.00 M |
| Discontinued operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |
| Net income | 134.00 M | 187.00 M | 257.00 M | 191.00 M | 163.00 M | 196.00 M | −39.00 M | 262.00 M | 582.00 M |
| YoY growth | −70.81% | 5.65% | 42.78% | 25.66% | 21.64% | 4.81% | −115.18% | 37.17% | |
| Dilution adjustment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |
| Preferred dividends | 1.00 M | 1.00 M | 1.00 M | 1.00 M | 0 | 0 | 0 | 0 | — |
| Diluted net income available to common stockholders | 133.00 M | 186.00 M | 256.00 M | 190.00 M | 163.00 M | 196.00 M | −39.00 M | 262.00 M | 582.00 M |
| Basic earnings per share (basic EPS) | 0.09 | 0.13 | 0.18 | 0.13 | 0.11 | 0.14 | −0.02 | 0.11 | 0.34 |
| YoY growth | −70.11% | 8.02% | 43.82% | 25.74% | 22.29% | 5.03% | −110.79% | −14.18% | |
| Diluted earnings per share (diluted EPS) | 0.09 | 0.13 | 0.18 | 0.13 | 0.11 | 0.14 | −0.02 | 0.11 | 0.34 |
| YoY growth | −69.91% | 8.39% | 43.53% | 25.45% | 21.97% | 4.88% | −110.82% | −13.98% | |
| Average basic shares outstanding | 1.44 B | 1.44 B | 1.44 B | 1.44 B | 1.44 B | 1.44 B | 2.04 B | 2.31 B | — |
| Diluted shares outstanding | 1.44 B | 1.44 B | 1.44 B | 1.44 B | 1.45 B | 1.45 B | 2.04 B | 2.31 B | — |
| EBITDA | 441.00 M | 490.00 M | 546.00 M | 456.00 M | 431.00 M | 456.00 M | 640.00 M | 875.00 M | 2.40 B |
| YoY growth | −7.74% | 4.26% | 3.80% | −2.15% | −2.27% | −6.94% | 17.22% | 91.89% | |
| EBIT | 295.00 M | 337.00 M | 399.00 M | 315.00 M | 305.00 M | 324.00 M | 324.00 M | 511.00 M | 1.46 B |
| YoY growth | −14.49% | 3.37% | 8.42% | −0.63% | 3.39% | −3.86% | −18.80% | 62.22% | |
| Total operating expenses | −2.96 B | −3.07 B | −3.14 B | −3.04 B | −2.94 B | −3.01 B | −4.76 B | −5.23 B | −15.94 B |